Semaglutide reduces blood glucose in a glucose dependent manner by stimulating insulin secretion and lowering glucagon secretion when blood glucose is high. The mechanism of blood glucose lowering also involves a minor delay in gastric emptying in the early postprandial phase.
FITARO 0.5MG INJECTION
$30.00
| Packaging Type | Vial |
| Brand | FITARO 0.5 INJECTION |
| Manufacturer | INCEPTA PHARACEUTICAL LTD |
| Prescription/Non prescription | Prescription |
| Country of Origin | Made in India |
